Warm modern clinic interior with natural light and welcoming atmosphere

Pricing & Booking

Reserve today for $49. Early-access preorder price $799, regular price $1,299. One blood draw. Physician review included. Whole-body MRI included if a suspected cancer signal is detected.

Reserve Your Test for $49

Preorder $799 · Regular $1,299 · Save $500

What's Included

$799 preorder price. Everything you need for early cancer detection.

Reserve today for $49. Regular price $1,299. No surprise charges. No referral required.

Your miCheckup test is normally $1,299 CAD. During early access, a $49 reservation secures your $799 preorder price — a $500 savings. There are no surprise charges, no hidden fees, and no insurance coordination required.

microRNA Blood Test — A standard blood draw at a partner collection centre measures thousands of circulating microRNAs, creating your unique molecular profile
MCED Analysis — Your sample is analyzed by our validated microRNA algorithms, trained on thousands of peer-reviewed blood samples to detect signals across multiple solid tumor cancers1 2
Physician Review — A physician reviews your results with you and guides you through every next step
Whole-Body MRI (if indicated) — If a suspected cancer signal is detected, you receive a whole-body MRI at no additional cost — typically a $4,000+ expense on its own

Most multi-cancer testing approaches require separate payments for analysis and imaging. With miCheckup, the MRI is included at no extra cost if your microRNA test flags a suspected cancer signal.

Person in a warm medical consultation with reassuring atmosphere

Simple, transparent pricing.

$49

Reservation deposit today — secures your early-access preorder price

$799

Limited preorder price for early-access customers — regular price is $1,299

$0

Additional cost for whole-body MRI if a suspected cancer signal is detected — included in your test

Collection locations.

miCheckup is currently available across Ontario. Your blood draw is performed at a partner collection centre — the same familiar clinical setting as a routine blood test.

Available Now

Ottawa

Ontario

Our flagship collection location in Canada's capital. Convenient central location with flexible appointment scheduling.

Collection partner: Partner Collection Centre

Reserve for $49

Available Now

Toronto

Ontario

Multiple collection locations available across the Greater Toronto Area through our partner network.

Collection partner: Partner Collection Centre

Reserve for $49

Available Now

Hamilton

Ontario

Collection available through partner collection centres in the Hamilton area.

Collection partner: Partner Collection Centre

Reserve for $49

Available Now

London

Ontario

Collection available through partner collection centres in the London area.

Collection partner: Partner Collection Centre

Reserve for $49

Available Now

Kingston

Ontario

Collection available through partner collection centres in the Kingston area.

Collection partner: Partner Collection Centre

Reserve for $49

Available Now

More Ontario Locations

Ontario

miCheckup is available at partner collection centres across Ontario.

Collection partner: Partner Collection Centre

Reserve for $49

miCheckup is expanding across Canada. British Columbia, Alberta, and Quebec are planned for future availability. Contact us at hello@micheckup.com to be notified when miCheckup is available in your province.

Coverage Options

HSA, WSA, and employer coverage may apply.

miCheckup may qualify as an eligible expense through your health benefits.

miCheckup is a direct-pay laboratory service — no insurance claim is required and no referral is needed. However, many Canadians can offset the cost through existing health benefits:

Health Spending Accounts (HSA) — microRNA testing is a laboratory service that may qualify as an eligible healthcare expense under your employer HSA. Submit your miCheckup receipt for reimbursement through your plan administrator.

Wellness Spending Accounts (WSA) — Some employer WSA programs cover preventive health services, including laboratory testing. Check with your benefits provider to confirm eligibility.

Employer Wellness Programs — We offer group pricing for organizations interested in providing multi-cancer early detection testing as an employee benefit. Contact employers@micheckup.com for details.

We provide all documentation needed to support your HSA or WSA claim. If you're unsure whether your plan covers miCheckup, contact us — we'll help you determine eligibility.

Person reviewing financial documents in a modern office setting

The Screening Gap

Why isn't this covered by OHIP?

Canada screens for very few cancer types. miCheckup tests for many more.

Canada's publicly funded cancer screening programs cover very few cancer types — breast, cervical, and colorectal — and only for specific age groups.3 If you're asymptomatic and don't meet the criteria for those three programs, there is no pathway to cancer screening through the public system.

miCheckup represents a new category: a microRNA-based multi-cancer early detection (MCED) test. As this science matures and regulatory pathways develop, we anticipate that microRNA-based MMDS testing will become part of standard preventive care.

Until then, miCheckup is available as a direct-pay laboratory service. Early-access customers can reserve today for $49 and secure the $799 preorder price before the regular $1,299 price returns. miCheckup complements — not replaces — the public healthcare system. If a suspected cancer signal is detected, your physician guides you back into the Canadian referral system for follow-up.

View the Science

Ottawa skyline at sunrise with Parliament Hill in warm light

What exactly does the preorder price include?

+

Everything. The $799 early-access preorder price includes your microRNA blood test, MCED analysis for multiple solid tumor cancers, physician review of your results (video or in-person), and — if a suspected cancer signal is detected — a whole-body MRI at no additional cost. Regular price is $1,299. No hidden fees.

Is the MRI really included at no extra cost?

+

Yes. If your microRNA test identifies a suspected cancer signal, a whole-body MRI is arranged at no additional charge. This is included in both the $799 preorder price and the regular $1,299 price.

Can I use my Health Spending Account (HSA)?

+

In many cases, yes. microRNA testing is a laboratory service that may qualify as an eligible expense under your employer HSA. Submit your miCheckup receipt to your plan administrator for reimbursement. We provide all necessary documentation.

Do I need a doctor's referral?

+

No. miCheckup is a direct-to-consumer laboratory service. Our clinical team provides the requisition. No prior approval from your physician is required.

Where can I get my blood drawn?

+

At a partner collection centre in Ontario — multiple locations available. The blood draw takes about 10 minutes, no fasting required.

When will I get my results?

+

Results are typically delivered within approximately 4–8 weeks of your blood draw. All results are reviewed by a physician before being shared with you.

Can I book if I'm outside Ontario?

+

miCheckup is currently available in Ontario only. Contact hello@micheckup.com to be notified when we expand to your province.

Is there a payment plan?

+

Your $49 reservation deposit secures the $799 preorder price. Regular price is $1,299. We're exploring flexible payment options for the remaining balance. If payment is a barrier, please reach out — we want to make testing accessible.

Important Safety Information

+

miCheckup is intended for adults at or above the age of majority in their province (18 or older in most provinces; 19 or older in British Columbia, New Brunswick, Newfoundland and Labrador, Nova Scotia, Northwest Territories, Nunavut, and Yukon). miCheckup is a multi-cancer early detection (MCED) test — an early warning test intended to identify a suspected cancer signal associated with multiple solid tumor cancers from a single blood draw. miCheckup does not detect all cancers and should be used in addition to routine cancer screening tests recommended by your healthcare provider.

Use of miCheckup is not recommended in individuals who are pregnant or planning pregnancy, under the age of majority in their province, currently undergoing active cancer treatment, or currently experiencing symptoms that may indicate cancer. If you are experiencing symptoms, please consult your physician directly.

Results should be interpreted by a healthcare provider in the context of your medical history, clinical signs, and symptoms. All miCheckup results are reviewed with you by a physician. A result of "no suspected cancer signal identified" does not rule out cancer. A result of "suspected cancer signal identified" is not a diagnosis — it requires confirmatory diagnostic evaluation by medically established procedures, which is why a whole-body MRI and physician follow-up are included in your miCheckup test.

If a suspected cancer signal is identified but cancer is not confirmed with further testing, it could mean that cancer is not present, or that testing was insufficient to detect cancer — including due to the cancer being located in an area or of a type not well represented in the miCheckup signal. False positive results (a suspected cancer signal identified when cancer is not present) and false negative results (no suspected cancer signal identified when cancer is present) do occur.

miCheckup is a complement to, not a replacement for, standard cancer screening programs. Continue all recommended screening — including mammography, Pap/HPV testing, and colorectal screening (FIT or colonoscopy) — as directed by your healthcare provider. Cancer diagnosis in Canada always requires a tissue biopsy confirmed by a pathologist. If a suspected cancer signal is identified, imaging and clinical workup by your healthcare team will determine the actual status. Many findings turn out to be benign after further investigation.

Laboratory/Test Information

+

miCheckup is a multi-cancer early detection (MCED) Laboratory-Developed Test (LDT), performed at an accredited Canadian medical laboratory certified by the Institute for Quality Management in Healthcare (IQMH). In Canada, LDTs are regulated as a clinical laboratory service under provincial and territorial laboratory oversight. Your blood sample is collected, processed, and analyzed entirely within Canada.

The miCheckup microRNA analysis is based on peer-reviewed research published in Scientific Reports (Nature Portfolio, 2024) and Cancers (MDPI, 2022), validated on thousands of peer-reviewed blood samples, with ongoing validation through the Ontario Health Study using 4,000+ Canadian blood samples.

Published validation shows greater than 99% specificity and greater than 90% sensitivity for the majority of cancer types in the current miCheckup panel of multiple solid tumor cancers. Performance may vary by cancer type and individual factors. For a detailed breakdown of sensitivity and specificity by cancer type, and the complete list of cancers currently in the miCheckup panel, visit The Science.

All personal health data is stored in Canada and handled in accordance with the Personal Information Protection and Electronic Documents Act (PIPEDA) and applicable provincial health privacy legislation, including the Personal Health Information Protection Act (PHIPA) in Ontario.

miCheckup is currently available in Ontario, expanding across Canada. For the full safety, regulatory, and performance disclosure, see Important Information.

References

+

Zhang J, Rui H, Hu H. "Noninvasive multi-cancer detection using blood-based cell-free microRNAs." Scientific Reports 14, 22136 (2024). doi.org
Zhang A, Hu H. "A Novel Blood-Based microRNA Diagnostic Model with High Accuracy for Multi-Cancer Early Detection." Cancers 14(6), 1450 (2022). doi.org
Canadian Cancer Society. Canadian Cancer Statistics 2024. cancer.ca/statistics